Sunday 18 August 2019 ,
Sunday 18 August 2019 ,
Latest News
  • Govt to do everything for development of medical science: PM
  • 4 killed in Narsingdi road crash
  • BCB appoints Domingo as Tigers head coach
  • Rawhide sales suspended till Sunday
  • College student dies of dengue in Faridpur
  • Artificial intelligence to help better manage Dhaka
21 January, 2019 00:00 00 AM

FDA approves expanded use of Adacel (Tdap) vaccine for repeat vaccination

drugs.com
FDA approves expanded use of Adacel (Tdap) vaccine for repeat vaccination

The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat vaccination to help protect against tetanus, diphtheria and pertussis. It is now the first and only Tdap vaccine in the U.S. approved for a repeat dose in people 10 through 64 years of age 8 years or more after the first vaccination. Adacel is also the only Tdap vaccine available in a syringe made without natural rubber latex, which may help reduce risk to patients with an allergy.

"While strong vaccination programs are in place for young adolescents, a single Tdap immunization does not offer lifetime protection against pertussis due to waning immunity," said David P. Greenberg, M.D., Regional Medical Head North America at Sanofi Pasteur. "The licensure of Adacel as the first Tdap vaccine in the U.S. for repeat vaccination is an important step for eligible patients and offers flexibility for health care providers to help manage their immunization schedules."

The FDA licensure was based on clinical data from a study of the safety and effectiveness of repeat Adacel vaccination in adults. In the study of more than 1,300 adults (aged 18 through 64 years), participants received either Adacel vaccine or a tetanus-diphtheria (Td) vaccine 8-12 years after a previous dose of Adacel vaccine. The results of the study published in the Journal of the Pediatric Infectious Diseases Society showed a second dose of Adacel vaccine in adults administered 8-12 years after a previous dose found no significant differences in adverse events between vaccine groups.1 A total of 87.7% of Tdap vaccine recipients (n=999) and 88.0% of Td vaccine recipients (n=328) reported at least 1 injection-site reaction.

Sanofi Pasteur has provided the results of the study to the CDC's Advisory Committee on Immunization Practices for their consideration in future recommendations.

The U.S. Centers for Disease Control and Prevention (CDC) currently recommends a single dose of Tdap vaccine for adolescents and adults, and for pregnant women during every pregnancy. Tdap helps protect adolescents and adults and may prevent the spread of the infection to babies and young children who are still building immunity. Despite the CDC-recommendation, nearly three of four adults have not received the Tdap vaccine.

Indication for Adacel Vaccine

Adacel vaccine is given to people 10 through 64 years of age to help prevent tetanus (lockjaw), diphtheria, and pertussis (whooping cough).

Important Safety Information for Adacel Vaccine

Adacel vaccine should not be given to anyone who has had a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine. Some signs of severe allergic reactions are hives, swelling of the throat, low blood pressure, shock, and difficulty breathing. If you begin to experience any of these signs seek treatment right away. These reactions are rare and usually occur before leaving the doctor's office.

For one presentation of Adacel, the tip caps of the prefilled syringes may contain natural rubber latex, which may cause allergic reactions in latex‐sensitive individuals. The vial stopper is not made with natural rubber latex.

Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness), Guillain‐Barré syndrome (severe muscle weakness), brachial neuritis (inflammation of nerves in the arms), or an Arthus‐type reaction (severe, exaggerated swelling involving an injection site) after a previous dose of a tetanus toxoid‐ or pertussis antigen‐containing vaccine.

Fainting can occur shortly after injecting vaccines, including Adacel.

If you notice any other problems or symptoms following vaccination, please contact your health care professional promptly.

After the first and second dose of Adacel, the most frequently reported side effects were pain, swelling, and redness at the injection site; headache, body ache or muscle weakness, tiredness, muscle aches, and general discomfort.

 

Comments

Most Viewed
Digital Edition
More story
Editor Speaks

Editor Speaks

The scientists agree that breast milk is the best. The mammary gland is a modified sweat gland – an important organ of female reproductive system…
Breastfeeding

Breastfeeding

Babies who are breastfed have fewer illnesses and are better nourished than those who are fed other drinks and foods. If all babies were fed only breastmilk…
World Breastfeeding Week

World Breastfeeding Week

Forld Breastfeeding Week is celebrated every year from 1 to 7 August to encourage breastfeeding and improve the health of babies around the world. It…
Busted: 14 myths about breastfeeding

Busted: 14 myths about breastfeeding

1. Breastfeeding is easy. Babies are born with the reflex to look for their mother’s breast. However, many mothers need practical support with positioning…
Breastfeeding and medication

Breastfeeding and medication

The advantages of breastfeeding for both a mother and her baby are well known. Many nursing mothers may need to be treated with drugs, either for a chronic…
Infant and young child feeding

Infant and young child feeding

Key facts •    Every infant and child has the right to good nutrition according to the "Convention on the Rights of the Child".…
Breast anomalies –an experience

Breast anomalies –an experience

Mammals are provided with mammary glands. Breast exist in the female as well as male (though in rudimentary state). It secret milk and is an accessory…
Stomach-protecting medicines can trigger allergies

Stomach-protecting medicines can trigger allergies

JOHANNES ANGERER Stomach-protecting drugs are widely used. Now, using quantitative prescribing data from Austria, a study conducted by MedUni Vienna in…
BIT organizes master-class for Complex PCI of Higher-risk and Indicated Patients

BIT organizes master-class for Complex PCI of Higher-risk and Indicated Patients

Across the world, Illustrious surgeons, physicians and medical scientists often conduct, workshops and master-classes on complex subjects, developments,…
Diabetic women more likely to have stillborn baby, study finds

Diabetic women more likely to have stillborn baby, study finds

Diabetic women are more than four times more likely to have a stillborn baby than those without the condition, a new study has found. Researchers from…
FDA approves Accrufer (ferric maltol) for the treatment of Iron deficiency in adults

FDA approves Accrufer (ferric maltol) for the treatment of Iron deficiency in adults

Shield Therapeutics plc, a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces that the U.S. Food and Drug…
Vitamin A linked to lower odds of common skin cancer

Vitamin A linked to lower odds of common skin cancer

Wondering if you can do more than slap on some sunscreen to prevent skin cancer? A new study suggests that getting more vitamin A may help. The study…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting